Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekCapital Regulatory News (TEK)

Share Price Information for TekCapital (TEK)

Share Price is delayed by 15 minutes
Get Live Data
5.80    -0.10 (-1.69%)
Bid:
5.70
Ask:
5.90
Spread: 0.20 (3.509%)
Market Cap: £14.92m
TEK Live PriceLast checked at - London Stock Exchange

Intraday TekCapital Share Chart

Guident Update

4 Feb 2022 07:00

RNS Number : 6693A
Tekcapital plc
04 February 2022
 

 

 

 

4th February 2022

Tekcapital Plc

("Tekcapital", the "Company" or the "Group")

Portfolio Company Update: Guident Ltd ("Guident")

 

Tekcapital Plc (AIM: TEK), (OTCQB: TEKCF), the UK intellectual property investment group focused on transforming university technologies into valuable products that can improve people's lives, is pleased to announce that portfolio company Guident has provided an update on some of their recent activities.

 

1. Guident Ltd, the developer of software for improving the safety of autonomous vehicles (AVs) and delivery robots, announced that they have filed their 8th patent application covering improvements to their remote monitoring and control centre for AVs. U.S. patent application #17/579,203 entitled: "Near Real-Time Data and Video Streaming System for a Vehicle, Robot or Drone".

 

"We have achieved what we believe to be one of the lowest glass-to-glass (camera-to-monitor) latencies in the market. This technology is required by teleoperations (which enables a human to remotely monitor and control an autonomous vehicle) as it facilitates rapid image analysis for quick decision making," said Harald Braun, Chairman & CEO of Guident Ltd.

 

2. Guident attended the 2022 Consumer Electronic Show in Las Vegas, and whilst there engaged in meetings with potential customers and partners regarding its teleoperation solution, and was delighted with their feedback and desire to collaborate. Discussions are on-going and the Company will update the market as appropriate.

 

3. Additionally, Guident has announced progress with their regenerative shock absorbers (RSA). They reported that their RSA prototypes have been fabricated and are being evaluated by independent test facilities to confirm their performance and capabilities. Guident is currently in discussions with potential customers and strategic partners to both manufacture and use their RSA's. The picture of the RSA prototype can be found under the following link: https://guident.co/shock-abs.jpg

 

 

The Market

According to Triton Market Research "the last mile AV delivery market autonomous vehicle market is expected to reach $41.7 billion by 2028 with a CAGR of 19%. Contactless or "touch-free" delivery is in high-demand since the COVID 19 pandemic and Guident believes this increased demand will accelerate the roll-out of land-based delivery drones for food and medicines to improve their availability and reduce the costs of these deliveries.

About Guident

Guident commercializes new technology to enhance the safety, efficiency and utility of autonomous vehicles and ground-based drones using its proprietary IP & software apps for remote monitoring and control. To learn more please visit www.guident.co

 

 

 

About Tekcapital plc

Tekcapital creates value from investing in new, university-developed discoveries that can enhance people's lives and provides a range of technology transfer services to help organisations evaluate and commercialise new technologies. Tekcapital is quoted on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in the UK. For more information, please visit www.tekcapital.com.

 

LEI: 213800GOJTOV19FIFZ85

 

Tekcapital owns 100% of the share capital of Guident Ltd.

For further information, please contact:

 

Tekcapital Plc 

Via Flagstaff

Clifford M. Gross, Ph.D. 

SP Angel Corporate Finance LLP

(Nominated Adviser and Broker)

+44 (0) 20 3470 0470 

Richard Morrison/Charlie Bouverat (Corporate Finance)

Abigail Wayne / Rob Rees (Corporate Broking)

Flagstaff Strategic and Investor Communications

+44 (0) 20 7129 1474

Tim Thompson/Andrea Seymour/Fergus Mellon

 

Forward Looking Statements

This press release is for informational purposes only. The information herein does not constitute investment advice nor an offer to invest and may contain statements related to our future business and financial performance and future events or developments involving Guident or Tekcapital that may constitute forward-looking statements. These statements may be identified by words such as "expect," "look forward to," "anticipate" "intend," "plan," "believe," "seek," "estimate," "will," "project" or words of similar meaning. We may also make forward-looking statements in other reports, in presentations, in material delivered to customers, stakeholders and in press releases. In addition, our representatives may from time to time make oral forward-looking statements. Such statements may be based on the current expectations and certain assumptions of Guident' and/or Tekcapital's management. Please note that these are subject to a number of risks, uncertainties and factors, including, but not limited to those described in various disclosures. Should one or more of these risks or uncertainties materialise, or should underlying expectations not occur or assumptions prove incorrect, actual results, performance or achievements of Guident or Tekcapital may vary materially from those described explicitly or implicitly in the relevant forward-looking statement. Neither Guident nor Tekcapital intends, nor assumes any obligation, to update or revise these forward-looking statements in light of developments which differ from those anticipated.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUPUWCPUPPGMW
Date   Source Headline
10th Apr 20257:00 amRNS-RInnovative Eyewear Receives EU Certification
31st Mar 20255:34 pmRNSUnaudited Results to 31 December 2024
20th Mar 20257:00 amRNS$0.35m Contract Win
13th Mar 20257:00 amRNSCorporate Update & 2025 Outlook
17th Feb 20257:00 amRNS2024 Review - Year End Portfolio Update
14th Feb 20251:22 pmRNSNotification of Major Holdings
3rd Feb 20257:00 amRNSOversubscribed Fundraising of £2.3Million
30th Jan 20257:00 amRNS-RInnovative Eyewear announces Key Partnership
22nd Jan 202511:14 amRNSNotification of Major Holdings
21st Jan 20257:00 amRNSGuident Receives Significant New Patent Coverage
17th Jan 20259:13 amRNSPlacing of £0.5 million (c.$0.6m)
15th Jan 20257:00 amRNSGuident Corp. Appointment of Investment Banker
20th Dec 20247:00 amRNSPortfolio Company Update - Guident Ltd
4th Dec 20247:00 amRNSIssue of Shares to Advisers
25th Nov 20249:13 amRNS-RPortfolio Company Update - Innovative Eyewear
20th Nov 20244:26 pmRNSNotification of Major Holdings
20th Nov 20247:00 amRNSCorporate Update
15th Nov 20247:00 amRNSFundraising of £1.0 Million
30th Oct 20247:00 amRNSNew and Follow-on B2B Customer Orders
8th Oct 20247:00 amRNSCorporate Update
2nd Oct 20248:00 amRNSTekcapital Spins out GenIP onto AIM
25th Sep 20247:00 amRNSHalf Year Results
18th Sep 20247:58 amRNSGenIP plc Schedule One
16th Sep 20247:00 amRNSMultiple Placements of Products and B2B Progress
13th Sep 20241:37 pmRNSHolding(s) in Company
29th Aug 20247:00 amRNSPortfolio Company Update Innovative Eyewear Inc
13th Aug 20247:00 amRNSInnovative Eyewear 2nd Q24 Revenue increased 82%
1st Jul 202411:21 amRNSGrant of Share Options
21st Jun 20244:20 pmRNSResults of Annual General Meeting
30th May 20247:00 amRNSPortfolio Company Update - Innovative Eyewear
22nd May 20247:00 amRNSFinal Results year ended 31 December 2023
2nd May 20247:00 amRNSPortfolio Company Update Guident Q1 2024
26th Apr 20247:00 amRNSInnovative Eyewear Canadian Partnership
25th Apr 20247:00 amRNSInnovative Eyewear Patent Filings
18th Apr 20247:00 amRNSInnovative Eyewear Signs Brand Ambassador
17th Apr 20247:00 amRNSInnovative Eyewear Distribution Partnership
9th Apr 20247:00 amRNSPortfolio Company Update : Guident Ltd
5th Apr 20247:00 amRNSPortfolio Company Update : Guident Ltd
28th Mar 202410:20 amRNSNotification of Major Holdings
7th Mar 202411:15 amRNSNotification of Major Holdings
6th Mar 20247:00 amRNSIntellectual Property Update
29th Feb 20247:51 amRNSFundraising of £2.0 million
19th Feb 20247:00 amRNSPortfolio Company Update : Guident Ltd
15th Feb 202410:31 amRNSNotification of Major Holdings
15th Feb 20247:00 amRNSGuident Expands its Strategic Partnership
13th Feb 20242:24 pmRNSNotification of Major Holdings
1st Feb 20247:15 amRNSMicroSalt Admission to AIM First Day of Dealings
1st Feb 20247:01 amRNSNotice of Presentation on Investor Meet Company
24th Jan 20247:00 amRNSBellescura Plc - Disposal of Shares
12th Jan 20244:31 pmRNSLoan Agreement with Innovative Eyewear Inc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.